Clinical Trial Update: Low-Dose Prednisone or Methylprednisolone in Treating Patients With Newly Diagnosed Acute Graft-versus-Host Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating low-dose prednisone or methylprednisolone for newly diagnosed acute graft-versus-host disease, with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Graft-versus-host Disease

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Fred Hutchinson Cancer Center | Conditions: Graft Versus Host Disease, Recurrent Adult Acute Lymphoblastic Leukemia | Phase 3 | Status: COMPLETED | Results posted: 2014-10-09